Keyword: Rentschler Biopharma
News
09.10.2020
-
German CDMO Rentschler Biopharma has reached agreement with Pfizer and BioNTech to handle the downstream purification process for the partnership’s mRNA-based COVID-19...
Strategy & Management
14.09.2020
-
So far, the pharmaceutical industry — including CMOs/CDMOs — has responded well to the outbreak of the Covid-19 pandemic.
Strategy & Management
19.02.2020
-
Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient...
News
29.11.2019
-
Laupheim, Germany-based contract development and manufacturing organization (CDMO) for biopharmaceuticals, Rentschler Biopharma, is taking the first step in the expansion...
News
29.10.2019
- Rentschler Biopharma’s chairman of the board, Nikolaus F. Rentschler, together with CEO Frank Mathias have received the "EY Entrepreneur of the Year" award 2019 in the category...
Markets & Companies
28.10.2019
-
Last year, Rentschler Biopharma, a German contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced its "Strategy 2025."
News
09.10.2019
-
German biopharmaceuticals contract development and manufacturing organization Rentschler Biopharma is extending and deepening its existing collaboration in Japan with...
Plant Construction & Process Technology
16.04.2015
- GE Healthcare Life Sciences has handed over its 1000th ÄKTAprocess to Rentschler Biotechnologie for use in the expanded biopharmaceutical manufacturing capabilities Rentschler has...